Monthly Archives: October 2007

US court rules in favour of Bayer over Avelox patents

October 30th, 2007|

US court ruled in favour of Bayer the German drugs and chemicals maker, in a case in Dr Reddy's Laboratories had challenged the validity of two US patents for antibiotic Avelox.

Pfizer to develop and market Taisho’s schizophrenia drug

October 30th, 2007|

Pfizer Inc announced that the company has signed a letter of intent for the development and commercialization with Taisho Pharmaceutical Co

Novartis invest US$700m in Singapore

October 30th, 2007|

Novartis is investing US$700 million to build a new large-scale biotechnology facility in Singapore

BioAlliance presents the results of its New Entity – AMEP at ESGCT

October 30th, 2007|

BioAlliance Pharma presents research results for a new cancer therapy agent at the 15th congress of the European Society of Gene and Cell Therapy, Rotterdam, October 27-30.

The Centre plans to set up EPZs for traditional medicines

October 29th, 2007|

The Centre has proposed to set up export processing zones for traditional Indian medicines in partnership with private entrepreneurs to boost overseas sales of ethnic herbs, which stood at Rs 900 crore in 2006-07.

Genzyme launches Cholestagel in Europe

October 29th, 2007|

Genzyme Corp. has launched it’s first commercially available cardiovascular product Cholestagel (colesevelam hydrochloride), in Europe.

India & China share in global market has doubled : KPMG

October 29th, 2007|

India and China, share of emerging markets in the global pharmaceutical industry has more than doubled to $32 billion in 2006 from $15 billion in 2001 according to KPMG report

SCM Logistics Middle East 2007

October 29th, 2007|

SCM Logistics Middle East 2007 – the region's definitive conference for supply chain professionals in the manufacturing industry to be held at the Shangri-la Hotel, Dubai on 29 and 30 October 2007.

Small drug units form new association – SPIC

October 26th, 2007|

Small scale manufacturers of non-exempt states is coming together to form a new association called SME Pharma Industries Confederation (SPIC)

Ranbaxy launches osonase nasal spray

October 26th, 2007|

Ranbaxy  has launched its a nasal spray Osonase (Ciclesonide) aqueous in India used in the treatment of perennial and seasonal allergies

Glenmark signs marketing agreement with MeyerZall

October 26th, 2007|

Glenmark Pharmaceuticals’s its South African arm has signed a 10-year marketing and distribution rights agreement with MeyerZall Laboratories that will help in expanding its topical dermatology portfolio.

European Commission wants new IP protection layer

October 26th, 2007|

The European Commission wants to create a new layer of intellectual property protections because it says existing structures such as WIPO are not flexible enough.

Sanaria to set up new Malaria Vaccine Plant soon

October 26th, 2007|

Biotechnology company Sanaria, Rockville, plans to open a new malaria vaccine plant that was funded partially by a $29.3 million grant from the Bill & Melinda Gates Foundation and $3.5 million in federal small business grants

Bioinformatics market to grow at over 16%

October 26th, 2007|

Bioinformatics has made its place in the laboratory and R&D departments of every country, but US is leading the worldwide bioinformatics market finds out RNCOS in its recent research report

Almirall in agreement to acquire products from Shire

October 25th, 2007|

Spain-based Laboratorios Almirall has entered into a definitive agreement to acquire a portfolio of eight products from Shire for $213m (€151m)

Cipla gets tentative nod from USFDA for granisetron HCL

October 25th, 2007|

Cipla Ltd  has received tentative approval from the U.S. Food and Drug Administration for granisetron hydrochloride tablets

Galapagos ties up with Janssen on rheumatoid arthritis research

October 25th, 2007|

Galapagos has signed a deal potentially worth hundreds of millions of euros with Johnson & Johnson unit Janssen Pharmaceutica

Wyeth Pharma’s SNDA for Tygacil accepted by US FDA

October 25th, 2007|

The US  Food and Drug Administration  has accepted  Wyeth Pharmaceuticals’s  supplemental new drug application for the treatment of patients with community-acquired pneumonia (CAP).

Capsugel, is offering its Vcaps capsules for use in dry powder inhalation products

October 25th, 2007|

Capsugel, a division of Pfizer, is offering its Vcaps hydroxypropyl methyl cellulose (HPMC) capsules for use in dry powder inhalation products.

Bilcare intends to provide clinical research services

October 25th, 2007|

Bilcare, a pharma-packaging-to-clinical supplies manufacturing company, is positioning itself as a global provider of clinical research management services and expanding the footprint for the Cardiff facility to all of Europe.